Wine may protect against dementia

18 May 2008

Research conducted by scientists at the Sahlgrenska Academy at University of Gothenburg in Sweden suggests there may be constituents in wine that protect against dementia. The findings are based on 1,458 women included in the so-called Population Study of Women from 1968.

When they were examined by physicians they were asked to report how often they drank wine beer, and liquor by selecting from seven categories on a scale from never to daily. The researchers knew nothing about how much they drank on each occasion, or how correct the estimates were. 34 years after the first study, 162 women had been diagnosed with dementia. The results show that among those who reported that they drank wine, a considerably lower proportion suffered from dementia, whereas this correlation was not found among those who had reported that they regularly drank beer or liquor, the researchers noted.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight